Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,845 | -86,161 | -90,192 | -62,790 | -47,380 |
| Depreciation Amortization | N/A | 673 | 516 | 738 | 1,464 |
| Accounts receivable | 39 | N/A | N/A | N/A | 116 |
| Accounts payable and accrued liabilities | 87 | -3,450 | 928 | 2,194 | 1,542 |
| Other Working Capital | 100 | -868 | 6,235 | 4,595 | -4,738 |
| Other Operating Activity | 3,477 | 10,881 | 5,102 | 1,128 | 1,696 |
| Operating Cash Flow | $-3,142 | $-78,925 | $-77,411 | $-54,135 | $-47,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -8,693 | -23,884 | -9,438 | 10,019 |
| PPE Investments | N/A | -144 | -769 | -505 | -690 |
| Investing Cash Flow | $N/A | $-8,837 | $-24,653 | $-9,943 | $9,329 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,300 | 0 | 13,500 | 0 | 2,000 |
| Debt Repayment | N/A | -9,492 | -2,630 | -4,246 | -579 |
| Common Stock Issued | 0 | 94,788 | 58,172 | 119,793 | 35,315 |
| Common Stock Repurchased | N/A | N/A | N/A | -32 | N/A |
| Financing Cash Flow | $3,300 | $85,296 | $69,042 | $115,515 | $36,736 |
| Beginning Cash Position | 148 | 48,490 | 81,512 | 30,075 | 31,310 |
| End Cash Position | 306 | 46,024 | 48,490 | 81,512 | 30,075 |
| Net Cash Flow | $158 | $-2,466 | $-33,022 | $51,437 | $-1,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,142 | -78,925 | -77,411 | -54,135 | -47,300 |
| Capital Expenditure | N/A | -144 | -769 | -505 | -690 |
| Free Cash Flow | -3,142 | -79,069 | -78,180 | -54,640 | -47,990 |